{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:20:43Z","timestamp":1771654843786,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,6]]},"DOI":"10.7759\/cureus.16964","type":"journal-article","created":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T05:26:13Z","timestamp":1628313973000},"source":"Crossref","is-referenced-by-count":2,"title":["Myosin Heavy Chain 9 (MYH9)-Related Congenital Macrothrombocytopenia"],"prefix":"10.7759","author":[{"given":"Aswani","family":"Thurlapati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinandan","family":"Guntupalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14796","article-title":"Diagnosis of inherited bleeding disorders in the genomic era","volume":"179","author":"Sivapalaratnam S","year":"2017","unstructured":"Sivapalaratnam S, Collins J, Gomez K. Diagnosis of inherited bleeding disorders in the genomic era. Br J Haematol. 2017, 179:363-76. 10.1111\/bjh.14796","journal-title":"Br J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e32835fad03","article-title":"May-Hegglin anomaly and pregnancy: a systematic review","volume":"24","author":"Hussein BA","year":"2013","unstructured":"Hussein BA, Gomez K, Kadir RA. May-Hegglin anomaly and pregnancy: a systematic review. Blood Coagul Fibrinolysis. 2013, 24:554-61. 10.1097\/MBC.0b013e32835fad03","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref3","unstructured":"MYH9-related disease. (2014). Accessed. January 04, 2021: https:\/\/ghr.nlm.nih.gov\/condition\/myh9-related-disorder."},{"key":"ref4","unstructured":"MYH9-related disorder. (2020). Accessed. January 04, 2021: https:\/\/medlineplus.gov\/genetics\/condition\/myh9-related-disorder\/."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1220327","article-title":"MYH9-related platelet disorders","volume":"35","author":"Althaus K","year":"2009","unstructured":"Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost. 2009, 35:189-203. 10.1055\/s-0029-1220327","journal-title":"Semin Thromb Hemost"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfy117","article-title":"MYH9-related disorders display heterogeneous kidney involvement and outcome","volume":"12","author":"Tabibzadeh N","year":"2019","unstructured":"Tabibzadeh N, Fleury D, Labatut D, et al.. MYH9-related disorders display heterogeneous kidney involvement and outcome. Clin Kidney J. 2019, 12:494-502. 10.1093\/ckj\/sfy117","journal-title":"Clin Kidney J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-304725","article-title":"Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations","volume":"116","author":"Pecci A","year":"2010","unstructured":"Pecci A, Gresele P, Klersy C, et al.. Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations. Blood. 2010, 116:5832-7. 10.1182\/blood-2010-08-304725","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn277","article-title":"Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome)","volume":"23","author":"Pecci A","year":"2008","unstructured":"Pecci A, Granata A, Fiore CE, Balduini CL. Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome). Nephrol Dial Transplant. 2008, 23:2690-2. 10.1093\/ndt\/gfn277","journal-title":"Nephrol Dial Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/62282-myosin-heavy-chain-9-myh9-related-congenital-macrothrombocytopenia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:14Z","timestamp":1707507194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/62282-myosin-heavy-chain-9-myh9-related-congenital-macrothrombocytopenia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,6]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.16964","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,6]]}}}